Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
CareDx, Inc.
Bear Case (25th pct.)
-64.1% vs price
Base Case (Median)
-51.8% vs price
Bull Case (75th pct.)
-42.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $46.48 | -33.7% | Medium (25%) |
| Graham Number | $16.56 | -76.4% | Medium (40%) |
| EV/FCF | $33.81 | -51.8% | Medium (20%) |
Based on 3 out of 7 methods, CDNA appears overvalued at the current price of $70.16. The base case fair value of $33.81 implies 51.8% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.